Lovastatin

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (12:43, 10 January 2024) (edit) (undo)
 
(One intermediate revision not shown.)
Line 1: Line 1:
-
<applet load="" size="480" color="" frame="true" spin="on" Scene ="Lovastatin/Lovastatin/1" align="right" caption="Lovastatin, also known as Mevacor"/>
+
<StructureSection load='' size='340' side='right' caption='Lovastatin, also known as Mevacor' scene='Lovastatin/Lovastatin/1'>
===Better Known as: Mevacor===
===Better Known as: Mevacor===
* Marketed By: Merck & Co. <br />
* Marketed By: Merck & Co. <br />
Line 11: Line 11:
===Mechanism of Action===
===Mechanism of Action===
Lovastatin is rapidly hydrolyzed in vivo into its corresponding b-hydroxyacid, which is an inhibitor of [[HMG-CoA Reductase]] (HMGR), a highly regulated enzyme responsible for the committed step in cholesterol synthesis. Lovastatin outcompetes HMG-CoA, the substrate of HMGR, in binding to HMGR.<ref>PMID:7784310</ref>
Lovastatin is rapidly hydrolyzed in vivo into its corresponding b-hydroxyacid, which is an inhibitor of [[HMG-CoA Reductase]] (HMGR), a highly regulated enzyme responsible for the committed step in cholesterol synthesis. Lovastatin outcompetes HMG-CoA, the substrate of HMGR, in binding to HMGR.<ref>PMID:7784310</ref>
-
 
+
</StructureSection>
===Pharmacokinetics===
===Pharmacokinetics===
-
{| class="wikitable" border="1" width="48%" style="text-align:center"
+
<table style="background: cellspacing="0px" align="" cellpadding="0px" width="42%">
-
|-
+
<tr>
-
! colspan="7" align="center"| Statin [[Pharmacokinetics]] at 10mg Dosage.<ref>PMID:11907637</ref><ref>PMID:15198967</ref><ref>PMID:12686673</ref><ref>PMID:18176327</ref><ref>PMID: 17452418</ref><ref>PMID:12895195</ref>
+
<td style="width:100%; vertical-align:top;border-width:0px; border-style:inset">
-
|-
+
<div style="height:100%; width: 100%">
-
! Parameter
+
{{:Statin Pharmacokinetics}}
-
! [[Atorvastatin]] (Lipitor)
+
</div>
-
! [[Fluvastatin]] (Lescol)
+
</td>
-
! [[Lovastatin]] (Mevacor)
+
</tr>
-
! [[Simvastatin]] (Zocor)
+
</table>
-
! [[Rosuvastatin]] (Crestor)
+
-
! [[Cerivastatin]] (Baycol)
+
-
|-
+
-
! [[Pharmacokinetics#Tmax|T<sub>max</sub>]] (hr)
+
-
! 2.5
+
-
! 1
+
-
! 3
+
-
! 1.5
+
-
! 4
+
-
! 1.5
+
-
|-
+
-
! [[Pharmacokinetics#Cmax|C<sub>max</sub>]] (ng/ml)
+
-
! 27-66
+
-
! 448
+
-
! 10-20
+
-
! 7.3
+
-
! 4.34
+
-
! 3.43
+
-
|-
+
-
! [[Pharmacokinetics#Bioavailability_.28F.29|Bioavailability]] (%)
+
-
! 12
+
-
! 19-29
+
-
! 5
+
-
! 5
+
-
! 20
+
-
! 60
+
-
|-
+
-
! [[Pharmacokinetics#Protein_Binding|Protein Binding]] (%)
+
-
! 80-90
+
-
! 99
+
-
! 95
+
-
! 95
+
-
! 88
+
-
! 99
+
-
|-
+
-
! [[Pharmacokinetics#Half_Life_.28T1.2F2.29|T<sub>1/2</sub>]] (hr)
+
-
! 15-30
+
-
! 2
+
-
! 3
+
-
! 2.7
+
-
! 19
+
-
! 2.2
+
-
|-
+
-
! [[Pharmacokinetics#Area_Under_the_Curve_.28AUC.29|AUC]] (ng/ml/hr)
+
-
! 104
+
-
! ~150
+
-
! 33
+
-
! 125
+
-
! 48
+
-
! 14.5
+
-
|-
+
-
! [[Pharmacokinetics#Inhibitory_Concentration_.28IC50.29|IC<sub>50</sub>]] (nM)
+
-
! 154
+
-
! 198
+
-
! 800-4200
+
-
! 66
+
-
! 320
+
-
! 50-90
+
-
|-
+
-
! Equivalent LDL Reduction Dosage (mg)
+
-
! 10
+
-
! --
+
-
! 80
+
-
! 20
+
-
! 5
+
-
! --
+
-
|-
+
-
! Metabolism
+
-
! Hepatic <br/>(CYP3A4)
+
-
! Hepatic <br/>(CYP2C9)
+
-
! Hepatic <br/>(CYP3A4)
+
-
! Hepatic <br/>(CYP3A4)
+
-
! Not <br/>Metabolized
+
-
! Hepatic <br />(CYP2C8)
+
-
|}
+
===References===
===References===

Current revision

Lovastatin, also known as Mevacor

Drag the structure with the mouse to rotate

Pharmacokinetics

Statin Pharmacokinetics at 10mg Dosage
Parameter Atorvastatin (Lipitor) Fluvastatin (Lescol) Lovastatin (Mevacor) Simvastatin (Zocor) Rosuvastatin (Crestor) Cerivastatin (Baycol)
Tmax (hr) 2.5 1 3 1.5 4 1.5
Cmax (ng/ml) 27-66 448 10-20 7.3 4.34 3.43
Bioavailability (%) 12 19-29 5 5 20 60
Protein Binding (%) 80-90 99 95 95 88 99
T1/2 (hr) 15-30 2 3 2.7 19 2.2
AUC (ng/ml/hr) 104 ~150 33 125 48 14.5
IC50 (nM) 154 198 800 66 320 50-90
Equivalent LDL Reduction Dosage (mg) 10 -- 80 20 5 --
Metabolism Hepatic
(CYP3A4) 		Hepatic
(CYP2C9) 		Hepatic
(CYP3A4) 		Hepatic
(CYP3A4) 		None Hepatic
(CYP2C8)

For References, See References

References

  1. ↑ Corsini A, Maggi FM, Catapano AL. Pharmacology of competitive inhibitors of HMG-CoA reductase. Pharmacol Res. 1995 Jan;31(1):9-27. PMID:7784310


Proteopedia Page Contributors and Editors (what is this?)

David Canner, Alexander Berchansky

Retrieved from "http://52.214.119.220/wiki/index.php/Lovastatin"
Personal tools